These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

211 related items for PubMed ID: 7021424

  • 1. Host defenses in murine malaria: nonspecific resistance to Plasmodium berghei generated in response to Mycobacterium bovis infection or Corynebacterium parvum stimulation.
    Murphy JR.
    Infect Immun; 1981 Jul; 33(1):199-211. PubMed ID: 7021424
    [Abstract] [Full Text] [Related]

  • 2. Host defenses in murine malaria: analysis of the mechanisms of immunity to Plasmodium berghei generated in response to immunization with formalin-killed blood-stage parasites.
    Murphy JR.
    Infect Immun; 1979 Jun; 24(3):707-12. PubMed ID: 381198
    [Abstract] [Full Text] [Related]

  • 3. Host defenses in murine malaria: humoral immunity to Plasmodium berghei in mice.
    Murphy JR, Logie PS.
    Am J Trop Med Hyg; 1984 May; 33(3):347-56. PubMed ID: 6375406
    [Abstract] [Full Text] [Related]

  • 4. Host defenses in murine malaria: induction of a protracted state of immunity with a formalin-killed Plasmodium berghei blood parasite vaccine.
    Murphy JR, Lefford MJ.
    Infect Immun; 1978 Dec; 22(3):798-803. PubMed ID: 365770
    [Abstract] [Full Text] [Related]

  • 5. Host defenses in murine malaria: successful vaccination of mice against Plasmodium berghei by using formolized blood parasites.
    Murphy JR, Lefford MJ.
    Am J Trop Med Hyg; 1979 Jan; 28(1):4-11. PubMed ID: 373471
    [Abstract] [Full Text] [Related]

  • 6. Rodent malaria: BCG-induced protection and immunosuppression.
    Smrkovski LL, Strickland GT.
    J Immunol; 1978 Oct; 121(4):1257-61. PubMed ID: 100553
    [Abstract] [Full Text] [Related]

  • 7. Host defenses in murine malaria: characteristics of protracted states of immunity to Plasmodium berghei.
    Murphy JR.
    Infect Immun; 1983 Jun; 40(3):1240-4. PubMed ID: 6343244
    [Abstract] [Full Text] [Related]

  • 8. Endotoxin-induced serum factor kills malarial parasites in vitro.
    Taverne J, Dockrell HM, Playfair JH.
    Infect Immun; 1981 Jul; 33(1):83-9. PubMed ID: 7021427
    [Abstract] [Full Text] [Related]

  • 9. Host defenses in murine malaria: immunological characteristics of a protracted state of immunity to Plasmodium yoelii.
    Murphy JR.
    Infect Immun; 1980 Jan; 27(1):68-74. PubMed ID: 6987179
    [Abstract] [Full Text] [Related]

  • 10. Differential sensitivity in vivo of lethal and nonlethal malarial parasites to endotoxin-induced serum factor.
    Taverne J, Depledge P, Playfair JH.
    Infect Immun; 1982 Sep; 37(3):927-34. PubMed ID: 6752029
    [Abstract] [Full Text] [Related]

  • 11. Protection of mice against plasmodium and babesia infections: attempts to raise host-protective sera.
    Mitchell GF, Handman E, Howard RJ.
    Aust J Exp Biol Med Sci; 1978 Oct; 56(5):553-9. PubMed ID: 375903
    [Abstract] [Full Text] [Related]

  • 12. Corynebacterium parvum- and Mycobacterium bovis Bacillus Calmette and Guerin-induced granuloma formation in mice lacking CD4 and CD8.
    Senaldi G, Shaklee CL, Mak TW, Ulich TR.
    Cell Immunol; 1999 May 01; 193(2):155-61. PubMed ID: 10222057
    [Abstract] [Full Text] [Related]

  • 13. Glucan-enhanced immunogenicity of killed erythrocyte stages of Plasmodium berghei.
    Holbrook TW, Cook JA, Parker BW.
    Infect Immun; 1981 May 01; 32(2):542-6. PubMed ID: 7019074
    [Abstract] [Full Text] [Related]

  • 14. Lack of biological significance of in vitro Brugia malayi microfilarial cytotoxicity mediated by Propionibacterium acnes ("Corynebacterium parvum")-and Mycobacterium bovis BCG-activated macrophages.
    Fanning MM, Kazura JW.
    Infect Immun; 1986 May 01; 52(2):534-7. PubMed ID: 3516877
    [Abstract] [Full Text] [Related]

  • 15. Effects of BCG, Corynebacterium parvum, and methanol-extration residue in the reduction of mortality from Staphylococcus aureus and Candida albicans infections in immunosuppressed mice.
    Sher NA, Chaparas SD, Greenberg LE, Bernard S.
    Infect Immun; 1975 Dec 01; 12(6):1325-30. PubMed ID: 1107224
    [Abstract] [Full Text] [Related]

  • 16. Effects of Mycobacterium bovis BCG, bacterial lipopolysaccharide and hydrocortisone on the development of immunity to Plasmodium berghei.
    Ferraroni JJ, Douglass TG, Speer CA.
    Rev Inst Med Trop Sao Paulo; 1986 Dec 01; 28(1):36-45. PubMed ID: 3532283
    [No Abstract] [Full Text] [Related]

  • 17. Adjuvant protection against bacterial infection in granulocytopenic mice.
    Buhles WC, Shifrine M.
    J Infect Dis; 1977 Jul 01; 136(1):90-5. PubMed ID: 328788
    [Abstract] [Full Text] [Related]

  • 18. BCG, Corynebacterium parvum or Mycobacterium leprae added to cultures of BCG-primed mouse spleen cells cause an enhanced primary antibody response in vitro.
    Brown CA, Brown IN, Sljivić VS.
    Immunology; 1981 Jan 01; 42(1):67-73. PubMed ID: 7007221
    [Abstract] [Full Text] [Related]

  • 19. Effect of route of Mycobacterium bovis BCG administration on induction of suppression of sporozoite immunity in rodent malaria.
    Smrkovski LL.
    Infect Immun; 1981 Jan 01; 31(1):408-12. PubMed ID: 7012001
    [Abstract] [Full Text] [Related]

  • 20. Experimental cancer immunotherapy: comparison of tumor rejection if F344 rats given live Mycobacterium bovis (Strain BCG) and killed Corynebacterium parvum.
    Likhite VV.
    J Natl Cancer Inst; 1976 May 01; 56(5):985-9. PubMed ID: 994209
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.